These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22695156)

  • 41. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
    Im EJ; Saubi N; Virgili G; Sander C; Teoh D; Gatell JM; McShane H; Joseph J; Hanke T
    J Virol; 2007 Sep; 81(17):9408-18. PubMed ID: 17596303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge.
    Berry N; Ham C; Alden J; Clarke S; Stebbings R; Stott J; Ferguson D; Almond N
    J Gen Virol; 2015 Jul; 96(Pt 7):1918-29. PubMed ID: 25834093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trained Immunity and Susceptibility to HIV.
    Derrick SC
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
    Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
    J Virol; 1998 May; 72(5):4170-82. PubMed ID: 9557706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.
    Traina-Dorge V; Pahar B; Marx P; Kissinger P; Montefiori D; Ou Y; Gray WL
    Vaccine; 2010 Sep; 28(39):6483-90. PubMed ID: 20654666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.
    Gundlach BR; Lewis MG; Sopper S; Schnell T; Sodroski J; Stahl-Hennig C; Uberla K
    J Virol; 2000 Apr; 74(8):3537-42. PubMed ID: 10729127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.
    Genescà M; McChesney MB; Miller CJ
    J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.
    Sawai ET; Hamza MS; Ye M; Shaw KE; Luciw PA
    J Virol; 2000 Feb; 74(4):2038-45. PubMed ID: 10644378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques.
    Pahar B; Gray W; Fahlberg M; Grasperge B; Hunter M; Das A; Mabee C; Aye PP; Schiro F; Hensley K; Ratnayake A; Goff K; LaBranche C; Shen X; Tomaras GD; DeMarco CT; Montefiori D; Kissinger P; Marx PA; Traina-Dorge V
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.
    Van Rompay KK; Greenier JL; Cole KS; Earl P; Moss B; Steckbeck JD; Pahar B; Rourke T; Montelaro RC; Canfield DR; Tarara RP; Miller C; McChesney MB; Marthas ML
    J Virol; 2003 Jan; 77(1):179-90. PubMed ID: 12477823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques.
    Larson EC; Ellis AL; Rodgers MA; Gubernat AK; Gleim JL; Moriarty RV; Balgeman AJ; Menezes YK; Ameel CL; Fillmore DJ; Pergalske SM; Juno JA; Maiello P; White AG; Borish HJ; Godfrey DI; Kent SJ; Ndhlovu LC; O'Connor SL; Scanga CA
    Infect Immun; 2023 May; 91(5):e0055822. PubMed ID: 37039653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
    Wilks AB; Christian EC; Seaman MS; Sircar P; Carville A; Gomez CE; Esteban M; Pantaleo G; Barouch DH; Letvin NL; Permar SR
    J Immunol; 2010 Dec; 185(11):7097-106. PubMed ID: 21041730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
    Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
    J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuberculosis vaccines: hopes and hurdles.
    Ahsan MJ; Garg SK; Vashistha B; Sharma P
    Infect Disord Drug Targets; 2013 Oct; 13(5):318-21. PubMed ID: 24304353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS.
    Wang SW; Bertley FM; Kozlowski PA; Herrmann L; Manson K; Mazzara G; Piatak M; Johnson RP; Carville A; Mansfield K; Aldovini A
    AIDS Res Hum Retroviruses; 2004 Aug; 20(8):846-59. PubMed ID: 15320989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
    Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ
    J Virol; 2013 Apr; 87(8):4146-60. PubMed ID: 23345519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
    Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
    J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.
    Blancou P; Chenciner N; Ho Tsong Fang R; Monceaux V; Cumont MC; Guétard D; Hurtrel B; Wain-Hobson S
    J Virol; 2004 Feb; 78(3):1080-92. PubMed ID: 14722263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.